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Platelet actin nodules are podosome-like structures
dependent on Wiskott–Aldrich syndrome protein
and ARP2/3 complex
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Zoe Pikramenou4, Joshua Z. Rappoport5, John H. Hartwig6, Dylan M. Owen7, Adrian J. Thrasher3,
Stephen P. Watson1 & Steven G. Thomas1
The actin nodule is a novel F-actin structure present in platelets during early spreading.
However, only limited detail is known regarding nodule organization and function. Here we
use electron microscopy, SIM and dSTORM super-resolution, and live-cell TIRF microscopy to
characterize the structural organization and signalling pathways associated with nodule
formation. Nodules are composed of up to four actin-rich structures linked together by
actin bundles. They are enriched in the adhesion-related proteins talin and vinculin, have a
central core of tyrosine phosphorylated proteins and are depleted of integrins at the plasma
membrane. Nodule formation is dependent on Wiskott–Aldrich syndrome protein (WASp)
and the ARP2/3 complex. WASp / mouse blood displays impaired platelet aggregate
formation at arteriolar shear rates. We propose actin nodules are platelet podosome-related
structures required for platelet–platelet interaction and their absence contributes to the
bleeding diathesis of Wiskott–Aldrich syndrome.
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T
he actin cytoskeleton plays an important role in many
processes in platelets and their precursor cell the
megakaryocyte1,2. Actin is essential for the maintenance
of platelet morphology and for the rapid change in shape
following platelet activation. Actin also regulates platelet
surface glycoprotein signalling and thrombus stability3–8. In the
megakaryocyte, actin plays a critical role in the formation of
proplatelets and in mediating degradation of the extracellular
matrix (ECM) at sites of podosome formation9–12.
The actin cytoskeleton is assembled into a wide variety of
structures including ﬁlopodia, lamellipodia, stress-ﬁbres, podo-
somes, spreading initiation centres (SICs) and actin comets13–18.
These structures perform various functions and are regulated by a
mixture of common and speciﬁc pathways. For example, in
platelets, severing and uncapping of actin ﬁlaments by gelsolin19
provides free ﬁlament ends for ARP2/3 complex dependent actin
polymerization leading to a rapid increase in the F-actin content of
platelets19. Regulation and organization of ARP2/3-dependent
polymerization occurs downstream of members of the Rho
GTPases and nucleation promoting factors (NPFs). This is
illustrated in platelets by the critical role of Rac1 in lamellipodia
formation downstream of both tyrosine kinase and G protein-
coupled receptors4,20. In contrast, the signalling pathway to platelet
ﬁlopodia formation is unclear with contradictory results from
different Cdc42-knockout mouse studies. Pleines et al.21 used a
platelet and megakaryocyte-speciﬁc Cdc42 knockout to
demonstrate that this GTPase contributed to ﬁlopodia formation
downstream of the von Willebrand receptor complex, GPIb-IX-V,
but was dispensable for ﬁlopodia formation on ﬁbrinogen, which
binds to integrin aIIbb3. In contrast, Akbar et al.22 showed Cdc42
was required for ﬁlopodia on ﬁbrinogen and collagen. Furthermore,
Rif, another Rho GTPase, which has been shown to be important
for generating ﬁlopodia in other cells, is dispensable for platelet
ﬁlopodia formation23. Thus, there are cell- and agonist-speciﬁc
pathways of regulation of actin-based structures.
Recently, we have characterized two specialized actin structures
in megakaryocytes and platelets, namely podosomes and nodules,
respectively12,24. Podosomes are actin structures that were
originally described in osteoclasts and monocytic cells25. They
are short-lived, F-actin structures enriched in integrins, Src family
kinases (SFK) and the ARP2/3 complex, which are regulated by
the activity of Wiskott–Aldrich syndrome protein (WASp).
Protein localization is tightly regulated in podosomes and
underlies the distinctive structure of an F-actin, ARP2/3 and
WASp core surrounded by an integrin, talin and vinculin ring16.
We have shown that podosomes are required for megakaryocytes
to degrade basement membranes enabling proplatelets to reach
the bloodstream and form platelets17. We speculate that loss of
podosome formation may contribute to the reduced count and
altered size of platelets in patients with Wiskott–Aldrich
syndrome (WAS). However, this alone is unlikely to explain the
marked bleeding diathesis in WAS, as individuals with similar
platelets counts do not exhibit excessive bleeding.
The actin nodule is a novel actin structure found in platelets
during early adhesion and spreading on multiple ECM proteins24.
Nodules are absent in fully spread platelets where the F-actin is
rearranged into stress-ﬁbres. Like podosomes, they are F-actin-
rich structures that are dependent on actin polymerization and
SFK activity. They contain multiple signalling, actin-binding and
adhesion proteins, including Fyn, Rac1, ARP2/3 and integrins.
The rapid and early formation of nodules and their absence in
fully spread platelets led us to previously speculate that they may
play a role in lamellipodia and stress-ﬁbre formation24. There
have been no further studies on their regulation since our original
report and we know very little about their structural organization
and regulation. Nevertheless, the similar composition of nodules
and podosomes suggests that they may be related structures and
may therefore share a dependency on WASp.
There are two members of the WASp family in the mammalian
genome, N-WASp and WASp. N-WASp has a ubiquitous
distribution; WASp is restricted to haematopoietic cells26.
Patients with function-disrupting mutations or absence
of WASp suffer from WAS and display a range of immune
cell related phenotypes, microthrombocytopenia and excessive
bleeding27. WASp is required for formation of podosomes
in megakaryocytes9,12 and in humans this is associated with a
defect in platelet count, size and morphology (in mice, although
platelet count is reduced, size is not altered in the absence of
WASp28). However, it is likely that additional defects contribute
to the bleeding diathesis, which is disproportionate to the
reduction in platelet count. Although WASp is not required for
ﬁlopodia formation, it has been shown to be required for normal
spreading on ﬁbrinogen and clot retraction29–32. Thus, it appears
that multiple defects contribute to the bleeding diathesis in WAS
patients.
The aim of this study is to use state-of-the-art microscopy to
characterize the organization of proteins at actin nodules and to
determine the role of WASp in their regulation. We use a
combination of electron microscopy (EM), structured illumina-
tion microscopy (SIM) and direct stochastic optical reconstruc-
tion microscopy (dSTORM) super-resolution microscopy, and
total internal reﬂection ﬂuorescence (TIRF) microscopy to
monitor nodule formation and organization. Moreover, we
demonstrate a key role for WASp in nodule formation in human
and mouse platelets and that loss of nodules is associated with
impaired platelet adhesion and aggregation at arteriolar shear
rates, consistent with a critical role for nodules in adhesive
processes. Thus, we provide a possible molecular explanation for
the bleeding diathesis observed in WAS and for the role of WASp
in platelets, namely in regulating nodule formation.
Results
Actin nodules form an interconnected network in platelets.
‘Conventional’ epiﬂuorescent and confocal microscopy have a
physical spatial resolution ofB250 nm in XY and, at best, 500 nm
in Z planes due to the diffraction of light through the optics of the
microscope. Recently several techniques have been developed to
overcome this diffraction limit allowing spatial separation
of ﬂuorophores in the order of 10–100 nm in XY (known col-
lectively as super-resolution, reviewed in ref. 33). To investigate
the organization of actin and other proteins at the nodule at
nanometre resolution, we used SIM and dSTORM on platelets
spread on ﬁbrinogen-coated surfaces.
The actin cytoskeleton of human platelets was stained with
Alexa488-phalloidin and imaged using SIM, which gives an
approximate doubling in XY resolution when compared with
diffraction-limited epiﬂuorescence (Supplementary Fig. 1a–c).
This analysis revealed that actin nodules form part of an
interconnected actin network within spreading human platelets
(Fig. 1a). Nodules are interconnected via bundles of actin which
radiate from their dense actin core (Fig. 1a and Supplementary
Fig. 1d, arrows). SIM further reveals that single nodules imaged in
diffraction-limited epiﬂuorescence microscopy consist of between
1–4 bright foci of F-actin (Fig. 1a and Supplementary Fig. 1d,
arrowheads). This organization of nodules has been observed in
platelets from multiple donors in independent experiments.
These images are strikingly similar to scanning EM images of
platelet cytoskeletons, which show the actin nodules as closely
packed F-actin foci linked by actin ﬁbres (Fig. 1c).
We also spread mouse platelets on ﬁbrinogen, stained with
Alexa488-phalloidin and imaged using SIM. This again revealed
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that actin ﬁbres radiate from individual nodules (arrows in
Fig. 1b). Interestingly, while some nodules did appear as multiple
foci, in general the mouse actin nodules were smaller than
those observed in human and were predominantly found
as single actin-structures (Compare Fig. 1b with Fig. 1a and
Supplementary Fig. 1d).
Actin nodules link sites of adhesion to the cytoskeleton. To
further investigate the structure of nodules, we counterstained
human platelets with antibodies against the extracellular portion
the aIIb chain of the major platelet integrin aIIbb3, the actin-
binding proteins vinculin and talin or a pan-phosphotyrosine
antibody, and analysed them using SIM and dSTORM.
Using SIM the integrin can be seen to form a diffuse lawn over
the platelet surface except at actin nodules where it was
either absent from the nodule core or concentrated around the
outside of the nodule and absent from the core (Fig. 2a and
Supplementary Fig. 2). Line scans of ﬂuorescence intensity for
both actin and integrin conﬁrms that in the majority of nodules
(B90% of 774 nodules from 78 cells, n¼ 3 experiments) the
integrin is depleted from the actin-rich core region (Fig. 2a,b
dashed line and Supplementary Fig. 2). Furthermore, B50% of
platelets also contained some nodules where, in addition to the
central depletion, integrin was also enriched at the periphery of
the actin core (Fig. 2a,b solid line and Supplementary Fig. 2).
These data indicate that either there are subsets of nodules with
different patterns of integrin organization or perhaps, more likely,
the pattern of integrin distribution at nodules changes over the
lifetime of the nodule.
To further resolve the spatial distribution of integrin at the
actin nodule, we used dSTORM in TIRF to monitor aIIb on the
platelet surface (Fig. 3). This method is able to localize individual
molecules with a precision of B20 nm33. As before, a lawn of
aIIb was observed over the surface of the platelet with clearly
deﬁned integrin depleted zones in the centre of the actin nodules
(Fig. 3a). Experiments were also performed in which the integrin
was labelled after spreading and ﬁxation and these showed the
same pattern of integrin staining. This indicated that the depleted
region was not due to an unlabelled, internal pool of integrin
being brought to the surface during nodule formation.
Quantitative cluster mapping, which has been used to analyse
the distribution of protein molecules using dSTORM data34,
identiﬁes molecules displaying a more clustered distribution than
would be expected above random. This is presented as a cluster
heatmap with ‘hot’ colours identifying highly clustered molecules
(Fig. 3b) with a high L(r) value. Analysis of regions of platelets
where there are no nodules shows that aIIb is distributed evenly
over the surface of the platelet with no signiﬁcant clustering as
indicated by the prevalence of ‘cold’ colours in the heatmap
(Fig. 3b, top row). Binary threshold analysis of the cluster map
indicates very few regions of the platelet where there is no
integrin present. In comparison, analysis of the integrin
distribution at nodules shows that in all cases an integrin
Human - EPI Human - SIM
Mouse - EPI Mouse - SIM
Figure 1 | Comparison of SIM and epiﬂuorescent imaging of platelet actin nodules. Epi-ﬂuorescent images (left hand panel) of (a) human and
(b) mouse platelets spreading on ﬁbrinogen and stained for F-actin with Alexa488-phalloidin. The actin nodules in the boxed regions are shown enlarged
in the zoomed image. The right hand panel shows SIM images of the same platelets with increased detail seen in the boxed actin nodule shown in the
zoomed picture. Arrows indicate the actin ﬁbres radiating from and connecting different actin nodules together. (c) Scanning electron micrograph of a
representative human platelet displaying actin nodules. The right panel shows an enlargement of the boxed region in the left panel. Regions that could be
multiple bright foci of actin are indicated by the arrowheads and interconnecting ﬁbres by the arrows. Scale bars, 2 mm main image, boxed region: 0.5 mm.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8254 ARTICLE
NATURE COMMUNICATIONS | 6:7254 |DOI: 10.1038/ncomms8254 | www.nature.com/naturecommunications 3
& 2015 Macmillan Publishers Limited. All rights reserved.
depleted-zone is present at the centre of the nodule (Fig. 3b,
Middle row). This is in agreement with SIM data (Fig. 2). In
addition, some nodules show regions where integrin molecules
appear to be clustered adjacent to the depleted zone indicated by
‘hot’ colours in the cluster heat-map (Fig. 3b, bottom row).
Together, SIM and dSTORM data indicate that aIIbb3 is
excluded from the platelet surface below the actin nodules and
that the pattern of integrin around nodules changes during their
lifetime.
To further these studies, we used SIM to investigate the
location of additional actin-binding proteins. We focused on talin
and vinculin, which are often found at sites of cell adhesion and
are associated with podosomes16. SIM revealed that both talin
and vinculin are enriched at nodules (Fig. 4a,b), but their
distribution is different from that of F-actin. Quantifying the
pattern of line scan intensities of actin nodules counterstained
with either talin or vinculin into three categories (enriched at
nodule periphery; enriched at nodule core; or no obvious
enrichment) revealed that 76.4±4.3% and 74.6±9.4% of actin
nodules had talin and vinculin, respectively, enriched at their
periphery (Fig. 4c; 4660 nodules from Z60 cells, mean±s.d.,
n¼ 3 experiments for each protein). Similar to the results with
integrin, a mixture of patterns of localization was observed within
individual platelets, which again may reﬂect kinetic changes
during their lifetime.
Protein phosphorylation is important for platelet signalling
with many key proteins being phosphorylated during platelet
activation. Since nodules are dynamic structures and SFK activity
is required for their formation24 we investigated whether they
were signalling hubs using the presence of phosphotyrosine as a
marker of signalling. Both SIM (Fig. 5a) and dSTORM (Fig. 5b)
showed that small foci of phosphotyrosine activity are seen across
the platelet, and that greater than 90% of actin nodules label
strongly with the pan-phosphotyrosine antibody 4G10 (Fig. 5a,b;
546 nodules from 45 cells) indicating that they are sites of
signalling activity. Quantitative cluster mapping of 25 nodules
and 25 non-nodule regions from dSTORM images indicated that
the mean area (±s.d.) of clustered phosphotyrosine labelling at
the actin nodule is signiﬁcantly larger (B10 times) than clusters
seen throughout the remainder of the cell (0.065±0.018 mm2 at
nodules versus 0.007±0.007 mm2 outside of nodules; cluster
threshold L(r)¼ 100, Po0.001, Student’s t-test). Furthermore,
there is a signiﬁcant difference in the molecular density of
clustered phosphotyrosine between nodule-associated clusters
and the other clusters found throughout the platelet
(23,259±10,831 versus 15,130±14,408 ﬂuorescent events
detected mm 2; P¼ 0.008, Student’s t-test) (Fig. 5c). Taken
together, these data indicate that nodules are sites linking
interaction with the ECM and the actin cytoskeleton and are
sites of tyrosine phosphorylation-mediated signalling activity.
These proteins are also enriched at SICs; however, the absence of
key SIC markers at nodules indicates that nodules are distinct
from SICs (Supplementary Note 1 and Supplementary Fig. 3).
Actin nodules are dynamic highly regulated structures. The
super-resolution data suggest that actin nodules are hetero-
geneous structures that change their organization over their
lifetime. Lifeact-GFP, a 17-amino acid peptide that labels the
F-actin cytoskeleton35, can be used to monitor formation of
F-actin structures without interfering with either their formation
or function36,37. We have carried out several platelet function
assays comparing platelets from Lifeact-GFP mice with those
from wild-type mice and have found that expression of Lifeact-
GFP does not affect their function37 and therefore, we used
Lifeact-GFP mouse platelets and TIRF to visualize nodule
formation at the cell-matrix interface in real time.
Time-lapse TIRF movies of Lifeact-GFP platelets settling onto
ﬁbrinogen-coated glass-bottomed dishes demonstrated that
nodules rapidly form as platelets adhere and begin to spread
(Fig. 6a and Supplementary Movie 1). Subsequently, the platelets
continue to make nodules and ﬁlopodia as the cells spread out to
Actin Integrin αIIb Merge
Dotted line Dashed line Solid line
0.0 0.2 0.4 0.6 0.8 1.0
Distance along line (μm)
Actin
0.0 0.2 0.4 0.6 0.8 1.0
0
3,000
6,000
9,000
12,000
Distance along line (μm)
In
te
ns
ity
 
o
f a
ct
in
 (A
U)Integrin Actin
0.0 0.2 0.4 0.6 0.8 1.0
0
2,000
4,000
6,000
8,000
Distance along line (μm)
In
te
ns
ity
 o
f i
nt
eg
rin
 (A
U) Integrin IntegrinActin
Figure 2 | Organization of integrin at actin nodules using SIM. (a) Z-projections of a 3D SIM image of a human platelet stained for F-actin with
Alexa568-phalloidin (left panel), FITC-anti-aIIb (middle panel) and the merged image (right panel, actin¼magenta, integrin¼ green). Arrowheads in
middle panel indicate integrin depleted zones corresponding with the position of actin nodules. (b) Line scans showing the intensity of actin (magenta) and
integrin (green) ﬂuorescence signal at an area where there is no actin nodule (dotted line), at an actin nodule showing integrin depleted region (dashed
line) and at an actin nodule showing integrin depleted region and edge enrichment (solid line). Scale bars, 2 mm.
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form the characteristic spiky appearance of mouse platelets on
ﬁbrinogen. The number of actin nodules per mouse platelet
increases rapidly in the ﬁrst 20 s of spreading and then levels off,
averaging between four and six nodules per platelet (Fig. 6b). The
average diameter (measured at the widest point) of an actin nodule
in ﬁxed samples was 0.50±0.12mm (mean±s.d.) with the majority
(495%) of them in the range 0.25 to 0.62mm. The median lifetime
of an actin nodule was 22.1 s (25% percentile¼ 13.5 and 75%
percentile¼ 36.3;4400 nodules) (Fig. 6c).
We analysed the surface area of the nodules over their lifetime
to determine whether they change in their appearance. We
synchronized the size measurements by recording surface area in
the ﬁrst and last frame that the nodules were present and then at
25, 50 and 75% of their lifetime (Fig. 6d). These data indicated
that nodules are fairly uniform in size at appearance and
disappearance (surface area at appearance¼ 0.22±0.07 mm2 and
at disappearance¼ 0.22±0.07 mm2, mean±s.d.); however, over
the course of their lifetime they increase in size by up to 50% at
STORM image Cluster heat map
Binary threshold
showing ‘holes’
Region with
nodule
Region with
nodule
Region without
nodule
TIRFM STORM image - integrin
0 50 100 150
 TIRFM widefield image - actin
L(r)
Figure 3 | Quantitative analysis of integrin at actin nodules using dSTORM. (a) Human platelet stained with Alexa488-phalloidin and imaged for F-actin
using diffraction limited TIRF to identify the nodules (left panel) and Alexa647-anti-aIIb and imaged using super-resolution dSTORM TIRF (right panel).
Actin nodules and the corresponding integrin depleted zones are indicated by arrows. (b) Quantitative cluster mapping analysis of integrin localization on
the platelet surface (different cells to that shown in part (a)). One micrometre square regions of interest were taken around regions without (top row) and
with (middle and bottom rows) actin nodules. For each sample, the left hand panel shows the dSTORM picture, the middle panel shows the cluster heat
map and the right hand panel shows the thresholded image showing the integrin depleted zones detected in the distribution of integrin on the platelet
surface. The dotted yellow line indicates the position of the F-actin dense core. The actin nodule in the middle row shows no clustering of the integrin
around the nodule whereas the one seen in the bottom row appears to show integrin clustering (arrows). Scale bar, a: 2 mm, b: 0.5mm.
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mid-lifetime (0.31±0.09 mm2). This increase was signiﬁcant
compared with that at appearance and disappearance
(Po0.001; One way ANOVA & Tukey’s multiple comparison).
This change may reﬂect the ‘ﬂattening’ down of the nodules
onto the surface rather than a change in size. We investigated
this further by imaging the same actin nodules in both TIRF
and Epiﬂuorescence (Supplementary Movie 2). Increased actin
polymerization will result in increased ﬂuorescence intensity in
both modalities. However, we observed a consistent increase in
TIRF intensity above that of Epiﬂuorescence (Fig. 6e) suggesting
that the nodules were increasing in size and also moving
downwards in Z, and therefore into the higher intensity
region of the TIRF evanescent wave38. This movement in Z was
quantiﬁed by inputting the TIRF intensity values from 118
nodules (n¼ 3 experiments) into equation 4 (ref. 39) to generate
the mean (±s.d.) distance moved towards the substrate. This was
calculated as 34.6±19.0 nm, which is in the order of the size of
integrins40. These data support the hypothesis that nodules
both increase in size, due to actin polymerization, and change
their position in Z during their lifetime. We also measured the
lateral displacement or mobility of individual actin nodules
from TIRF timelapses and found all actin nodules are ﬁxed in
their location (Supplementary Fig. 4). Together these data
indicate that actin nodules are formed rapidly upon platelet
activation/adhesion, are tightly controlled in terms of size
and lifetime and are immobile in XY but move towards the
substrate in Z. These properties are also observed for
megakaryocyte podosomes; however, in contrast to podosomes,
we have shown that actin nodules do not degrade the
ﬁbrinogen matrix (Supplementary Note 2 & Supplementary
Fig. 5).
WASp is required for actin nodule formation. Podosome for-
mation in megakaryocytes requires the action of the protein
WASp9,12. In view of the similarities to podosomes, we
investigated whether nodule formation also requires WASp.
Platelets from mouse models either lacking WASp (WASp KO)28,
or expressing a mutant form of WASP that has a critical tyrosine-
residue mutated rendering it unable to be activated (WASp
Y293F) 41, were spread on ﬁbrinogen and stained with phalloidin.
Control mouse platelets displayed nodules as previously described
(Fig. 7a,b and Supplementary Fig. 6). However, nodules were
absent in WASp KO and WASp Y293F platelets, even though
adhesion on ﬁbrinogen was not altered and both ﬁlopodia and
lamellipodia formation was similar to controls (Fig. 7a and
Supplementary Fig. 6). Small bright actin foci were occasionally
seen, but these were not observed in all cells and had a
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Figure 4 | Organization of talin and vinculin at actin nodules using SIM. SIM images of human platelets stained with Alexa488-phalloidin (left panel) and
(a) Alexa568-anti-vinculin (middle panel) or (b) Alexa568-anti-talin. The merged images are shown in the right hand panel (actin¼magenta, vinculin/
talin¼ green) showing localization of vinculin and talin at actin nodules. In (a) and (b), arrows indicate the actin-rich nodule core and arrows head the ring
of vinculin or talin around this core. (c) Quantiﬁcation of the pattern of localization of talin and vinculin at the actin nodules by line scan intensity proﬁles.
The line scan proﬁle was scored as either enriched around the nodule; enriched at the centre of the actin nodule core; or no obvious enrichment at the
nodule and the percentage of nodules displaying each pattern was plotted. Bars represent mean±s.d. from three independent experiments. In total 738
nodules were measured for talin and 667 nodules were measured for vinculin. Scale bars, 2 mm.
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morphology that was distinct from nodules (Fig. 7a).
Measurement of the platelet surface area showed a small
(B10%) but signiﬁcant reduction in surface area when
compared with litter-matched controls (Fig. 7c).
To investigate the role of WASp in actin nodule formation
in human platelets, we analysed platelet spreading from two
WAS patients. Patient #1 had a c.134 C4T mutation in
WASp resulting in a p.T45M missense alteration, which
disrupts the interaction with WASp interacting protein
(WIP)42. Patient #2 had a c.IVS6þ 2T4C mutation, which
affects splicing and is predicted to give rise to WASp null
platelets43,44. Both sets of patient platelets were able to adhere
and spread on ﬁbrinogen but actin nodules were absent
(Fig. 7d,e). Furthermore, quantiﬁcation of spreading showed
a signiﬁcant reduction in platelet surface area for patient #2
(WASp null; 21.5±10.5 mm2 versus 25.0±13.2 mm2 for control,
P¼ 0.02. Data are mean±s.d. analysed by ANOVA and
Tukey’s multiple comparison) and a reduction, albeit non-
signiﬁcant, for patient #1 (22.2±11.7 mm2 versus 25.0±13.2 mm2
for control, P¼ 0.09) (Fig. 7f). Taken together these data
indicate that WASp is required for the formation of nodules
in both mouse and human platelets and also contributes to
spreading.
WASp recruits ARP2/3 complex to form actin nodules. In light
of the key role for WASp in nodule formation, we characterized
the role of the ARP2/3 complex in actin nodule formation.
Pre-treatment of mouse platelets with an inhibitor of ARP2/3
activity completely blocked spreading and actin nodule formation
on a ﬁbrinogen-coated surface (Supplementary Fig. 7 and
Supplementary Movie 3). Although this indicated that ARP2/3 is
required for actin nodule formation, this blockage could result
from inhibition of spreading per-se. To understand the interplay
between WASp and ARP2/3 in terms of nodule formation, con-
trol and WAS patient platelets were labelled for p34, a subunit of
the ARP2/3 complex, to determine whether localization was
affected in cells which could not make nodules. In control pla-
telets displaying nodules (Fig. 8a, top row), ARP2/3 was seen as
small punctate foci throughout the platelet, with larger and more
intense foci observed at nodules (Fig. 8a, arrows). However, in
WAS patient samples, which did not form nodules, no bright foci
of ARP2/3 labelling were observed, whereas the small punctate
foci across the platelet appeared unaltered (Fig. 8a, bottom panel).
In fully spread human platelets lacking nodules, the pattern of
ARP2/3 was the same in both control and WAS patient samples,
that is, the small punctate foci of p34 were observed across
the platelet with an enrichment of ARP2/3 and actin at the
Actin pTyr Merge
0
50
100
150
pTyr
*
Actin
*
L(r
)
Figure 5 | SIM and dSTORM imaging of protein phosphorylation at actin nodules. (a) SIM images of a human platelet stained with Alexa488-phalloidin
(left panel) and Alexa568-anti-pTyr (middle panel) and the merged image (right panel, actin¼magenta, pTyr¼ green). The presence of tyrosine
phosphorylated proteins can be seen as punctate staining across the platelet with a greater intensity and larger foci observed at actin nodules (two
examples indicated by arrows). (b) TIRF image of Alexa488-phalloidin labelled human platelet (left panel) with arrows indicating the actin nodules and a
dSTORM image of the same cell labelled with Alex647-anti-pTyr (right panel). This conﬁrms the results seen with SIM in that tyrosine phosphorylated
proteins are more concentrated at actin nodules (arrows). The asterisk indicates an actin nodule that resolves as two separate foci of pTyr labelling in the
super-resolution image. (c) Enlargement of the boxed region from (b) of the pTyr signal at a single actin nodule (left panel). Quantitative cluster mapping of
the image (right panel) conﬁrms that phosphorylated proteins are highly clustered at the actin nodule as indicated by the high L(r) value (according to the
pseudocolour scale shown to the right of the cluster map). Scale bars, a–b: 2 mm, c: 0.5 mm.
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lamellipodia (Fig. 8b, arrows). Taken together these data are
consistent with a model in which nodule formation is dependent
on the activity of WASp, which recruits and activates ARP2/3
complex. However, ARP2/3 recruitment and activity at other
parts of the cell (for example, lamellipodia) is unaffected
by the absence of WASp or the presence of functionally
inactive WASp.
WASp is required for platelet aggregate formation under ﬂow.
We hypothesize that actin nodules are adhesive structures due to
their association with integrins and adhesion-related proteins.
However, although platelets from WASp KO mice and WAS
patients do not have nodules, they display only a mild spreading
defect in static adhesion and spreading assays. To further inves-
tigate this role in adhesion, we examined whether the absence of
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Figure 6 | Characterization of actin nodule dynamics by live cell TIRF imaging. (a) Frames taken from time-lapse TIRF movies of three representative
Lifeact-GFP mouse platelets spreading on ﬁbrinogen (See Supplementary Movie 1) showing the dynamic nature of actin nodule formation and turnover.
Arrows indicate turnover of three individual actin nodules. Time stamp¼min:s. Scale bar, 5 mm. (b) Quantiﬁcation of the mean number of actin nodules per
platelet over time (solid line). Dashed and dotted lines represent±s.d. (c) Frequency histogram of the lifetime of individual actin nodules. (d) Mean surface
area of individual actin nodules normalized for lifetime. Bars represent the mean surface area of the nodule at initial appearance (0% of lifetime),
disappearance (100% of lifetime) and at 25, 50 and 75% of their lifetime. Error bars indicate the s.d. For (b–d) data are means of 20 platelets from two
independent experiments. (e) Representative mean ﬂuorescence intensity plot of a single actin nodule imaged over time in both TIRF (dashed line) and
epiﬂuorescence (solid line). Intensity increases are larger in TIRF than in epiﬂuorescence indicating movement of the nodule in the z axis towards the
coverslip. This Z movement has been calculated in nm and is shown for this nodule in (f). Appearance of the nodule at T0 is set at 0 nm and movement
towards the coverslip is indicated by negative nm values. (g) Frequency distribution of movement in Z (in nm) of 118 nodules from three independent
experiments.
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WASp impairs platelet adhesion or aggregation under ﬂow con-
ditions. Mouse models of WAS exhibit a reduction in platelet
count and a normal platelet size compared with the severe
microthrombocytopenia associated with the human disease28,41.
The latter prevents interpretation of ﬂow studies on human
platelets and so studies were undertaken on WASp-KO platelets.
Whole blood from WT and WASp-KO mice was ﬂowed over
collagen at a shear rate of 3,000 s 1. While WT platelets adhered
and formed the characteristic 3D platelet aggregates (Fig. 9a),
WASp-KO platelets were only able to adhere to the collagen
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Figure 7 | WASp is required for the formation of actin nodules in mouse and human platelets. (a) SIM images of Alexa488-phalloidin labelled platelets
from wild type (left panel), WASp KO (middle panel) and WASp Y293F (right panel) mouse platelets. Platelets from both the WASp KO and WASp Y293F
did not form conventional actin nodules as seen in wild-type platelets. (b) Quantiﬁcation of the number of platelets displaying actin nodules. Data are
means±s.d. (n¼ 3). ***Po0.001 from one way ANOVA. (c) Quantiﬁcation of the surface area of spread platelets from wild type, WASp-KO and WASp-
Y293F mice. Data are means±s.d. (n¼ 3), *Po0.05 from one way ANOVA. Approximately 400 platelets were analysed for each genotype. (d) SIM
images of Alexa488-phalloidin labelled human platelets from control (left panel) and Wiskott–Aldrich syndrome patient (WAS patient#2—right panel).
Platelets from the patient samples did not form actin nodules as could be seen in the control samples. (e) Quantiﬁcation of the percentage of platelets per
ﬁeld of view displaying actin nodules. Data are means±s.d. (f) Quantiﬁcation of the surface area of spread platelets from control and WAS patients. Data
are means±s.d. *P¼0.02 from ANOVA and Tukey’s multiple comparisons. More than 125 platelets were analysed for each control and patient sample.
Scale bars, 2mm.
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surface as monolayers and small aggregates (Fig. 9b and
Supplementary Movie 4). Quantiﬁcation of the surface area
covered by the aggregates demonstrates that WASp-KO platelet
aggregates covered just under 50% of the surface area of WT
controls (Student’s t-Test, P¼ 0.0097, 10 ﬁelds of view from n¼ 3
experiments; Fig. 9c). Using ﬂuorescence intensity as a measure of
aggregate volume, we conﬁrmed that WASp-KO platelets formed
a monolayer and signiﬁcantly smaller aggregates than WT
controls (P¼ 0.0411; Fig. 9d). This effect is speciﬁc to a
functional defect with the WASp-KO platelets and not due to
the reduced platelet count as WT blood with platelet count
matched to those of the WASp KO platelets displayed normal
aggregate formation at 3,000 s 1 (Supplementary Fig.8). As
platelet–platelet interactions appeared to be affected by the
absence of WASp, we performed low shear ﬂow (600 s 1) over
ﬁbrinogen, which mediates platelet–platelet adhesion (Fig. 9e,f
and Supplementary Movie 5). We observed a greater than 50%
reduction in adhesion in the WASP KO compared with the WT
and those platelets that did adhere were less spread (Fig. 9g,h).
Taken together these results support the idea that nodules play a
role in both platelet adhesion to the ECM substrate and
ﬁbrinogen-mediated platelet-platelet interactions. Thus, this
indicates that adhesion via actin nodules is important for
platelet capture under high shear ﬂow conditions.
Discussion
This study has used cutting-edge microscopy to characterize actin
nodule structure and function, in both human and mouse
platelets, at high spatial and temporal resolution. dSTORM and
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Figure 8 | Comparison of Arp2/3 localization in control and WAS patient platelets. (a) SIM images of human platelets stained with Alexa488-phalloidin
(left panel) and Alexa568-anti-p34 (middle panel) and the merged image (right panel, actin¼magenta, p34¼ green). The localization of ARP2/3 complex
at actin nodules can be observed in control platelets (top row, arrows indicate two examples); however, in WASp platelets no actin nodules and therefore
no bright foci of ARP2/3 complex were observed. (b) The localization of ARP2/3 complex at lamellipodia in fully spread platelets is the same in both
control and WAS patient samples indicating that ARP2/3 complex activity downstream of other NPFs is unaffected by the loss of WASp. Scale bars, 2 mm.
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SIM provide a detailed image of protein localization in platelets to
within B20 and B100 nm, respectively, which is a considerable
advance over conventional light microscopy. In addition,
dSTORM has enabled quantitative analysis of protein distribu-
tion. This has revealed that nodules in human platelets are
composed of up to four actin centres linked by actin bundles and
display differential organization of adhesion-related proteins.
Furthermore, using platelets from WAS patients and a mouse
model of the disease, we demonstrate that nodules are
WASp-dependent structures and provide evidence that they are
important for platelet aggregate formation and stability under
ﬂow conditions. We propose that the loss of nodules in platelets
contributes to pathological bleeding in WAS patients.
The enhanced resolution provided by SIM and dSTORM, and
studies on mutant mice, has allowed us to conclude that nodules
are platelet podosome-like structures formed during the early
stage of spreading. We were able to rule out that nodules
represent an alternative, early adhesion-related structure, namely
SICs18, through the demonstration that they do not co-localize
with the SIC markers RACK1 or RNA and the distribution of
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Figure 9 | Effect of WASp KO on platelet adhesion and aggregation under ﬂow conditions. Differential interference contrast (DIC) microscopy images of
a representative ﬁeld of view (FOV) from (a) WTand (b) WASp-KO mouse blood ﬂowed over collagen-coated capillaries at a shear rate of 3,000 s 1 (left
panel) with an enlargement of the boxed region (right panel). The failure of WASp-KO platelets to form aggregates can clearly be seen. Quantiﬁcation of
the aggregates in terms of their (c) size and (d) volume. DIC images of (e) WTand (f) WASp-KO mouse blood ﬂowed over ﬁbrinogen coated capillaries at
a shear rate of 600 s 1 (left panel) with an enlargement of the boxed region (right panel). The reduction in both the number of platelets adhered and the
extent of their spreading is clearly observed and is quantiﬁed in (g) and (h). Scale bars, 10 mm. Bars in (c,d,g and h) represent mean±s.e.m. of 10 FOV per
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actin is different18. Nodules, like podosomes, have an actin-rich
core and a distinct ring of proteins16. In addition, nodule
formation is dependent on WASp and ARP2/3 activity. However,
nodules are distinct from podosomes on the basis of their
relatively small size and fast turnover rate (B10–40 s compared
with 5–15min for megakaryocyte podosomes12). A further
property of podosomes is their ability to interact with and
degrade the ECM. Megakaryocyte podosomes have been shown
to use MMPs to degrade the underlying substrate and this,
coupled with actin polymerization at the podosome core,
provides the force necessary to protrude through the basement
membrane to extend proplatelets into the bloodstream12.
Interestingly WASp-KO megakaryocytes, which do not form
podosomes, are unable to degrade the substrate and this may
explain the release of platelets in the bone marrow9,12. In
contrast, MMP inhibition does not affect nodule formation and
nodules are not involved in substrate degradation. This difference
is consistent with the shorter lifetime of nodules versus
megakaryocyte podosomes.
Super-resolution microscopy has been applied to the study of
podosomes to provide detail on their nanostructure45,46. dSTORM
imaging of podosomes in dendritic cells (DCs) found that
podosomes were interconnected by actin bundles radiating from
the dense actin core46, bearing a strong resemblance to the actin-
based interconnections of nodules in platelets. In DCs, the integrin
aMb2 was homogenously distributed as ‘islets’ over the surface of
the cell except at podosomes where it was completely excluded
from the actin core46. In osteoclasts, integrins have been reported
to localize to different regions of the podosome, with b3 integrins
tending to localize to the outer ring while b1 localizes to the core
(reviewed in ref. 16). Therefore, nodules are not alone in showing
a distinct pattern of integrin organization relative to their inner
core. In podosomes, this exclusion has been linked to regions of
the membrane that are in close contact with the ECM46 and
presumably is due to physical exclusion of surface molecules. In
this study we observe an increase in the apparent size of actin
nodules during their lifetime and have shown that this increase is
due to both increased actin polymerization (this study and ref. 24)
and movement of the nodule closer to the substrate. This actin
polymerization-induced downward movement of the membrane
towards the substrate could explain the physical exclusion of
integrins from these regions47.
The adhesion-related proteins talin and vinculin are character-
istic of the ring structure of podosomes in many cell types
including megakaryocytes16. However, in DCs, talin and vinculin
have been shown to have a differential patterning around the
podosomes. Talin exhibited a similar distribution to the integrin
(homogenously distributed but depleted from the podosome
core), whereas vinculin was enriched around the actin core and
along the radiating actin bundles46. In platelets, using SIM, we see
both talin and vinculin throughout the platelet with enrichment
of both around the nodule core. Both talin and vinculin have been
shown to be important for mechano-sensing48,49. This role is
achieved through the ability of talin to link the actin cytoskeleton
to activated integrins, which supports adhesion to the ECM50 and
platelet–platelet interactions51. The link between actin and
integrins is reinforced by the binding of vinculin. The vinculin
head domain binds to sites along the talin rod domain, and its tail
domain binds to actin52,53. The role of vinculin in reinforcing,
rather than being essential for mechano-sensing, is highlighted by
the increase in bleeding times observed in vinculin-null mice
despite platelet function being unaffected54. The dynamic,
interconnected nature of actin nodules and the organization of
integrins and adhesion-related proteins at these structures lead us
to predict that actin nodules play a role in mechano-coupling
between platelets and the substrate or platelets and other platelets
as proposed in Fig. 10. Furthermore, the observation that
moesin and a-actinin molecules that are known to link actin
ﬁlaments to membranes and to be involved in mechano-sensing,
respectively55–57, are enriched at actin nodules (Supplementary
Fig. 9), provides further (indirect) evidence for this hypothesis.
Our lab has previously shown that SFK and actin polymeriza-
tion is required for stable platelet aggregate formation under ﬂow
conditions58. We have shown here that the actin polymerization
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Figure 10 | Schematic showing structural organization of the actin nodule. Actin nodules are an interconnected array of structures that consist of (i) a
central WASp—ARP2/3 dependent actin core, which is rich in tyrosine phosphorylated proteins, (ii) a region under the core which is depleted of aIIbb3
integrin, (iii) a ring structure containing talin and vinculin and (iv) actin ﬁlaments which radiate out to other nodules. We hypothesize that the actin
polymerization-driven downward movement of the membrane (red arrow) causes the physical exclusion of integrin from the centre of the nodule. This
generates tension in the actin ﬁlaments linking adjacent actin nodules (purple arrows) and so plays a mechano-sensory role important for maintaining
platelet adhesion in blood ﬂow.
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required for nodule formation is dependent on the WASp-ARP2/
3 axis as WASp-KO platelets do not have nodules. However,
ARP2/3 activity downstream of other NPFs (for example, Scar/
WAVE59) is unaffected as WASp-null platelets are still able to
form lamellipodia and correctly localize ARP2/3 to lamellipodia
in spread platelets. Our data show that while WASp-KO platelets
have a small defect in spreading under static assays, it is under
conditions mimicking arterial shear rates that the major effect is
observed. WASp-KO platelets do not adhere as efﬁciently to
collagen or ﬁbrinogen under ﬂow conditions and form only
monolayers and small aggregates on collagen at high shear rates.
Consistent with this, nodules can be seen in platelets spreading on
other substrates such as collagen or VWF (plus botrocetin)24. The
formation of nodules, however, is most prevalent in platelets
spreading on ﬁbrinogen. Fibrinogen is a ligand for the aIIbb3
integrin and is primarily involved in platelet–platelet interactions
in thrombus formation. This dependency on WASp implicates a
role for actin nodules in platelet-substrate and platelet-platelet
adhesion under shear and may underlie the increase in bleeding
in WAS patients and unstable primary platelet plugs in mouse tail
bleeding assays in the absence of WASp31.
In summary, we have provided strong evidence for the role of
WASp in platelets. We show that it is required for the formation
of actin nodules, structures, which share some similarities with
podosomes, and demonstrate that it is required for robust
aggregate formation under ﬂow conditions.
Methods
Reagents. Human Fibrinogen (Plasminogen, von Willebrand Factor and Fibro-
nectin depleted) was obtained from Enzyme Research Laboratories (Swansea, UK).
Horm collagen was obtained from Takeda (High Wycombe, UK). Alexa488-ﬁbri-
nogen, Alexa488-phalloidin, Alexa568-phalloidin, Anti-rabbit-Alexa568 (A-11036),
Anti-mouse-Alexa568 (A-11031) and Anti-mouse-Alexa647 (A-21235) secondary
antibodies were purchased from Life Technologies (Paisley, UK). The 35-mm
uncoated glass bottomed dishes with No1.5 coverslips were obtained from MatTek
Corporation (Massachusetts, USA). Monoclonal Anti-vinculin (clone hVIN-1,
V9131), Anti-Talin (Clone 8d4, T3287), 10% neutral buffered Formalin solution,
monoclonal Anti-Moesin (Clone 38/87, M7060) and anti-a-actinin (A2543) were
purchased from Sigma (Poole, UK). Monoclonal Anti-Phosphotyrosine (clone 4G10,
05-1050), Anti p34-Arc(ARPC2, 07-227) and ARP2/3 complex inhibitor 1 (CK666)
were purchased from Merck-Millipore (Middlesex, UK). Monoclonal Mouse Anti-
Human CD41 (aIIb)-FITC (clone 5B12, F708801-2) was obtained from Dako UK
(Cambridgeshire, UK). Mouse Anti-RACK1 (clone20/RACK1) was purchased from
BD Transduction Laboratories (Oxford, UK, 610178). Sytox-Green was purchased
from Life Technologies (Paisley, UK). GM6001 was purchased fromMerck Millipore
(Watford, UK). Unless speciﬁed otherwise, antibodies were used at a dilution of
1:250 of the supplied stock solution. All ﬂuorescent secondary antibodies and
phalloidin were used at a 1:300 dilution.
Mice. The 9- to 12-week-old C57Blk6, Lifeact-GFP60, WASp KO28 or WASp
Y293F41 mice were maintained in IVCs under 12 h light/dark cycle at a constant
temperature of 20 C with food and water given ad libitum at BMSU, Birmingham
University, UK. All experiments were performed in accordance with UK laws
(Animal [Scientiﬁc Procedures] Act 1986) with approval of local ethics committee
(Birmingham Animal Welfare and Ethical Review Board—AWERB) under a Home
Ofﬁce approved project licence.
Platelet preparation. Human blood samples for platelet isolation were donated by
healthy volunteers under the following licence: ERN_11-0175 ‘The regulation of
activation of platelets’ (UoB). Washed platelets were prepared as previously
described4. In brief, blood was drawn by venipuncture from healthy volunteers into
sodium citrate and acid/citrate/dextrose. Platelet-rich plasma (PRP) was prepared
by centrifugation of whole blood at 200 g for 20min. The platelets were then
isolated from PRP by centrifugation at 1,000 g for 10min in the presence of
prostacyclin (0.1 mgml 1). The pellet was resuspended in modiﬁed Tyrodes buffer
(129mM NaCl, 0.34mM Na2HPO4, 2.9mM KCl, 12mM NaHCO3, 20mM
HEPES, 5mM glucose, 1mM MgCl2; pH 7.3) containing 0.1 mgml 1 prostacyclin.
The platelets were washed once via centrifugation (1,000 g for 10min) and
resuspended at the desired concentration with modiﬁed Tyrodes buffer.
Washed platelet samples of mouse were prepared as previously described4. In
brief, blood was drawn from CO2 terminally anaesthetized mice from the vena cava
and taken into 100ml of acid/citrate/dextrose. PRP was obtained by centrifugation
at 200 g for 6min. Washed platelets were prepared via centrifugation of PRP at
1,000 g in the presence of prostacyclin (0.1 mgml 1) for 6min. The pellet was
resuspended in modiﬁed Tyrode buffer to the desired platelet level.
Wiskott–Aldrich syndrome patients. This study was approved by the National
Research Ethics Service Committee West Midlands—Edgbaston (REC reference:
06/MRE07/36) and participants and controls gave written informed consent in
accordance with the Declaration of Helsinki.
Patient #1 c. 134C4TWASP mutation predicting a p. T45M missense
alteration. This disrupts binding of WASp to WIP binding leading to increased
WASp degradation42. This patient expressed very low levels of WASp.
Patient #2 c. IVS6þ 2T4C mutation that affects splicing and is predicted to
give rise to WASp null platelets43,44. This patient expressed no WASp.
Platelet spreading and staining. For ﬁxed cell imaging experiments, washed and
rested platelets were diluted to 2 107 cellsml 1 in modiﬁed Tyrodes buffer and
allowed to spread on glass bottomed dishes coated with ﬁbrinogen (100 mgml 1)
for 30min at 37 C. Adhered cells were rinsed brieﬂy twice with phosphate buffered
saline (PBS) and ﬁxed for 10min with 10% formalin solution. Fixed samples were
washed three times with PBS and also between each step of the staining procedure.
Fixed platelets were treated with 50mM NH4Cl for 10min to quench residual
formalin ﬂuorescence, permeabilized with 0.1% Triton X-100 in PBS for 5min and
then stained with antibodies or phalloidin as required. Samples for N-SIM imaging
were mounted in Hydromount and stored at room temperature. Samples for
dSTORM imaging were stored in PBS at room temperature and protected from
light until imaged. When required, platelets were treated with the ARP2/3 inhi-
bitor, CK666 (10 mm)61,62, or Monoclonal Mouse Anti-Human CD41 (aIIb)-FITC
for 10min at 37 C before spreading. Following imaging (see below), platelet
surface area was measured using ImageJ (NIH, Bethesda, USA). Data were analysed
using Graphpad Prism v6 (Graphpad, California, USA).
Treatment of platelets with the MMP inhibitor GM6001. Washed human
platelets at 2 107 cellsml 1 were treated with 100 mM GM6001, or the same
volume of DMSO as a vehicle control, for 10min at 37 C before being spread for
30min on Alexa488-ﬁbrinogen-coated coverslips. Platelets were then ﬁxed in
formalin, permeabilized, stained for actin with Alexa568-phalloidin and imaged by
z-stack confocal microscopy using a Leica SP2 inverted confocal with the 63
objective. Five ﬁelds of view (59 59mm) were taken per treatment, per experi-
ment (n¼ 3; a total of 4360 platelets per treatment). Platelet number per ﬁeld of
view, surface area and number of nodules mm 2 were calculated using the Nikon
NIS Elements v4.1 software.
Flow-adhesion assay. Blood from three WT and three WASP-KO mice was
drawn into sodium heparin (10Uml 1) and PPACK (D-phenylalanyl-L-prolyl-L-
arginine chloromethyl ketone–40 mM). Glass capillaries, 0.1 1mm internal dia-
meter (Camlab, Cambridge, UK) were coated with 100mgml 1 Horm collagen or
100 mgml 1 ﬁbrinogen overnight at 4 C then blocked with 5mgml 1 heat-
inactivated BSA in PBS for 1 h at room temperature. The capillaries were mounted
on the stage of an inverted microscope (DM IRB; Leica), connected to a Harvard
pump driven ﬂow system and rinsed through with PBS to remove the BSA block.
The blood was pre-incubated with DiOC6 (3,30-dihexyloxacarbocyanine iodide–
2 mM) for 10min before perfusion through the chamber at 37 C at the shear rate
and duration indicated in the text and ﬁgure legend. Platelet aggregates were
washed with modiﬁed-Tyrode’s buffer at the same ﬂow rate as the blood for 5min
and then immediately imaged by DIC and z-stack ﬂuorescence microscopy on a
Zeiss Axiovert 200M with a 63 objective. Ten ﬁelds of view, along the length of
the capillary, per ﬂow experiment were imaged. For ﬂow over Horm collagen
platelet aggregate formation was assessed in ImageJ by thresholding the ﬂuores-
cence image to identify the aggregates. The mean surface area (mm2) of individual
thrombi was assessed in both WT and KO. The mean ﬂuorescence intensity of the
aggregates was then calculated as a measure of the aggregate volume. To test the
effect of reduced platelet count on platelet aggregate formation, samples of WT
mouse blood had the platelet count recorded before being split in half; one aliquot
was centrifuged at 200  g. for 6min to produce (PRP) and a red blood cell
fraction. The PRP had PGI2 (0.1 mgml 1 PGI2 per ml PRP) added and was spun
for a further 6min at 1,000  g to pellet the platelets. This platelet-poor plasma
(PPP) was added back to the red cell fraction to generate reconstituted blood with a
reduced platelet count. The second aliquot was left untreated, except for the
addition of an equivalent concentration of PGI2. WT and platelet-depleted blood
were then mixed in the appropriate ratios to give blood with platelet counts ranging
from 1,200 to 282 103 plateletsml 1. For analysis of the ﬁbrinogen ﬂow data the
number of platelets per ﬁeld of view (10 per experiment) were manually counted
using the ImageJ plugin ‘Cell counter’. Individual platelets were then scored as
being (1) unspread, (2) having ﬁlopodia, (3) having lamellipodia and expressed as a
percentage of the total platelets counted in that ﬁeld of view. Student’s t-tests were
carried out in Graphpad Prism v6 to assess signiﬁcance.
Total internal reﬂection ﬂuorescence microscopy. Live Lifeact-GFP platelets were
imaged using an Olympus IX81 Inverted microscope with a 60x Plan Apo 1.49NA
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oil-immersion objective and a Hammamatsu ORCA-R2 C10600 12-bit CCD.
Samples were excited with a 491-50 Diode type laser. For the dual TIRF—
Epiﬂuorescence live cell imaging of actin nodules a 150 objective (UAPON
150XOTIRF, 1.45 NA, Olympus) was used with the same Olympus TIRF micro-
scope. The 491-nm laser was set at the same power and gain, with the angle of the
laser altered to achieve TIRF (with a penetration depth of 100 nm) and then
immediately switched to wideﬁeld (Epi) illumination. Images were taken every 2 s
and drift in Z was minimized with Olympus Z-drift correction (ZDC). Images were
acquired using Xcellence Advanced Live Cell Imaging System 1.1. Post-imaging
analysis was performed using Nikon NIS Elements v4.1 and ImageJ 1.47v.
To calculate the nodule movement in Z, regions of interest (ROIs) were drawn
around nodules that were seen to appear and disappear within the timeframe of the
movie. The intensity of both the TIRF and Epi channels were measured and plotted
against time. The vast majority of nodules showed a much greater increase in
intensity in TIRF than in Epi, indicating movement towards the coverslip. With the
assumption that the contribution to intensity from actin polymerization was
minimal the movement in Z can be calculated from the TIRF intensity values over
time using equations 1–439:
I ¼ I0e zd ð1Þ
Where I0 is the intensity of the laser, z the distance from the coverslip and d the
penetration depth (a function of TIRF angle and refractive index). Assuming that
pixel value is proportional to the intensity of the TIRF ﬁeld then
P ¼ CI ð2Þ
Where P is the pixel intensity value and C is a constant, which depends on detector
sensitivity, detector gain and ﬂuorophore concentration. We know that these
factors remain constant between TIRF and Epi images then C remains the same for
different time points. Therefore, the ratio of pixel intensities at two time points
equals
P1
P2
¼ I1
I2
¼ e d z1  z2ð Þ ð3Þ
This rearranges to
z1  z2 ¼  1d log
P1
P2
 
ð4Þ
Using this equation the movement in Z of an actin nodule between each time point
was calculated. From this the overall movement of an actin nodule, from ﬁrst
appearance to disappearance, was plotted against time. Values for each nodule were
calculated in Excel 2010 and graphs plotted in Graphpad Prism v6.
Structured illumination microscopy. Samples were imaged on a Nikon N-SIM
system consisting of a Ti-E stand with Perfect Focus, 100 1.49 NA TIRF objective
lens, Nikon LU5 laser bed (488 and 561 nm laser lines), 3D SIM grating and Andor
DU897 EMCCD camera. Images were captured using Nikon NIS Elements v4.1
and reconstructed using slice reconstruction in NIS elements. Post-imaging
analysis was performed using NIS Elements v4.1 and ImageJ 1.47v.
STORM imaging and cluster analysis. Samples were imaged on a Nikon
N-STORM system in dSTORM mode consisting of a Ti-E stand with Perfect Focus,
100 1.49 NA TIRF objective lens, Agilent MLC400 high power laser bed (647 nm
laser line) and Andor DU897 EMCCD camera. Samples were imaged in a PBS
buffer containing MEA (100mM) and GLOX (10% v/v) to induce ﬂuorophore
blinking63. Twenty thousand frames were captured using Nikon NIS Elements v4.1
and reconstructed using STORM analysis module 1.1. Samples were drift corrected
and rendered using Gaussian rendering. Spots present in the ﬁnal reconstructed
images represent individually identiﬁed ﬂuorescent blinking events. Post-imaging
analysis was performed using Nikon NIS Elements v4.1. For information: the
median localization precision, a measure used to assess quality of super-resolution
images64, routinely achieved for 4G10 imaging was 12.8 nm (range 1.58 to 37.6 nm)
and for CD41 it was 17.9 nm (range 2.8–66.4 nm), calculated from ﬁve images.
Cluster analysis was performed on the dSTORM data in MATLAB using a custom
made algorithm as described by Owen et al.34, based on Ripley’s K-function and
Getis and Franklin’s Local Point Pattern analysis and described brieﬂy here.
The K-function, K(r), for a molecule, j, within an analysed region of area A
containing n molecules in total is deﬁned as:
KðrÞj ¼
A
n
Xn
i¼1
dij where dij ¼ 1 if dijor; else 0 ð5Þ
Where dij is the distance from molecule j to molecule i. In essence, this value is the
number of molecules found within a radius r of molecule j, divided by the mean
molecular density (n/A) of the region. Since the value of K(r) scales as r2 the
K-function is typically linearized to generate the L-function such that
L(r)¼ sqrt(K(r)/p) so:
LðrÞj ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
A
np
Xn
i¼1
dij
s
where dij ¼ 1 if dijor; else 0 ð6Þ
Here, the value of L(r) was computed for each molecule in a region. For analysis,
the region of interest was set at 1 mm2, and the spatial scale analysed (r) was set to
50 nm. Thus,
Lð50Þj ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
A
np
Xn
i¼1
dij
s
where dij ¼ 1 if dijo50; else 0 ð7Þ
To generate a pseudo-coloured cluster map, the values of L(50) at each point, j,
where interpolated onto a 5 nm resolution grid (Matlab ‘v4’ interpolation
algorithm). This cluster map could then have an upper and lower threshold applied
to them to generate binary maps. Areas of the map below the lower threshold were
deﬁned as being holes—where the local molecular density is low relative to the
mean molecular density, whereas areas above the upper threshold were deﬁned as
clusters. For integrin analysis the lower binary threshold was set at L(50)¼ 20 and
the upper binary threshold was set at L(50)¼ 70. For pTyr analysis the upper
binary threshold for clustering was set at L(50)¼ 100. Twenty-ﬁve ROIs containing
actin nodules and 25 without were analysed for pTyr clustering quantiﬁcation. All
dSTORM analyses were performed on human platelets.
SEM prep and imaging. Platelet cytoskeletons were isolated by permeabilizing
cells with PHEM buffer (60mM Pipes, 25mM Hepes, 10mM EGTA, and 2mM
MgCl2) containing 0.75% Triton X-100 for 2min. Cytoskeletons were then ﬁxed
with 1% glutaraldehyde in PHEM for 10min Water washed coverslips of platelet
cytoskeletons were rapidly frozen, freeze-dried, and coated with platinum and
carbon. Replicas were picked up on carbon-formvar-coated copper grids and
examined with a JEOL JEM-1200 EX transmission electron microscope at an
accelerating voltage of 80 kV.
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